BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in RCUS — Arcus Biosciences, Inc.
CIK 1520354
Paris, I0
Position in RCUS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$35,742,685
-$4,467,436 QoQ
Shares Held
1,654,754
-1.9% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,095,512,918 across 139 Biotechnology names. RCUS ranks #19 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
848,047 | $378,686,906 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
273,120 | $211,023,436 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
885,201 | $167,347,247 | |
| 4 | ARGX |
Argenx SE
|
129,147 | $94,309,595 | |
| 5 | INCY |
Incyte Corp
|
938,848 | $88,364,372 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,342,028 | $78,038,926 | |
| 7 | INSM |
INSMED Inc
|
467,753 | $76,486,969 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
907,533 | $68,146,652 |
All Filings in RCUS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,742,685 | 1,654,754 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $40,210,121 | 1,687,374 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $19,311,795 | 1,419,985 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $11,361,208 | 1,395,726 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $12,779,949 | 1,628,019 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $22,659,363 | 1,521,784 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $14,235,723 | 931,048 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $11,335,658 | 744,298 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $12,933,272 | 685,025 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $10,308,785 | 539,727 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $9,277,708 | 516,864 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,412,903 | 611,172 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $14,132,206 | 774,792 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $15,831,574 | 765,550 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $16,286,274 | 622,564 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $14,154,974 | 558,602 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $25,156,191 | 797,091 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $34,856,568 | 861,294 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $27,376,646 | 785,106 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $8,561,918 | 311,796 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||